Prediction of pathological complete response (pCR) by Homologous Recombination Deficiency (HRD) after carboplatin-containing neoadjuvant chemotherapy in patients with TNBC: Results from GeparSixto.
暂无分享，去创建一个
M. Rezai | P. Fasching | A. Schneeweiss | J. Reid | S. Loibl | M. Untch | V. Nekljudova | J. Blohmer | S. Kümmel | C. Jackisch | H. Eidtmann | S. Paepke | C. Salat | B. Gerber | G. Minckwitz | A. Hartman | K. Timms | P. Klare | D. Zahm | E. Elkin